Back to the complete issue
Wednesday, 14 July 2021

Slovenia donates vaccines to Egypt

Slovenia donates vaccines to Egypt: The 250k doses of the AstraZeneca vaccine heading to Egypt this week have been donated to us by Slovenia, the Health Ministry said in a statement.

This means that the shipment is not part of the 4.5 mn vaccines allocated to Egypt by the Covax scheme, as we suggested earlier this week. The initiative has so far delivered 2.6 mn, leaving us with 1.9 mn doses still to receive, which the health minister previously said would happen this month.

Reminder: AstraZeneca jabs won't get you into Europe after the EU announced yesterday that it would not recognize the India-manufactured AstraZeneca shots — the ones being administered in Egypt as part of the Covax program.

More vaccine doses expected this week: Egypt will receive its first 2 mn-dose shipment of the Pfizer / BioNTech mRNA vaccine by the end of this week, while the first unspecified shipment of Johnson & Johnson vaccines will also arrive this week.

The Health Ministry reported 108 new covid-19 infections yesterday, down from 110 the day before. Egypt has now disclosed a total of 283,320 confirmed cases of covid-19. The ministry also reported nine new deaths, bringing the country’s total death toll to 16,412.


Covid cases are again surging in the US and Europe as the highly-infectious delta variant continues to spread. Daily cases have more than doubled over the past three weeks spurred by delta, slowing vaccination rates and mass gatherings over the Independence Day holiday, the Associated Press reports. In Europe, countries are also seeing a resurgence of cases, forcing France, the Netherlands, Greece and Spain to introduce new restrictions. Vaccines will now be mandatory for healthcare workers in France and Greece, some areas of Spain have reintroduced curbs on gatherings, and a digital “health pass” needed to access large cultural and leisure venues will be rolled out in France.

In contrast, the UK is still pushing ahead with ending all precautionary measures on 19 July even as infection rates continue to rise.

J&J, AstraZeneca could modify covid-19 vaccines to prevent blood-clotting: AstraZeneca and Johnson & Johnson are carrying out early stage research to see if modifications could be made to their vaccines to reduce or eliminate the rare cases of blood-clotting, according to the Wall Street Journal. Scientists are discovering clues into the cause of extremely rare blood-clotting events, with AstraZeneca expected to possibly reengineer its shots next year. The clotting risk is 1 to 2 per 100k vaccinations for the AstraZeneca shot, while the J&J vaccine has a lower rate of 0.3 instances of the clotting issue per 100k doses.

Enterprise is a daily publication of Enterprise Ventures LLC, an Egyptian limited liability company (commercial register 83594), and a subsidiary of Inktank Communications. Summaries are intended for guidance only and are provided on an as-is basis; kindly refer to the source article in its original language prior to undertaking any action. Neither Enterprise Ventures nor its staff assume any responsibility or liability for the accuracy of the information contained in this publication, whether in the form of summaries or analysis. © 2022 Enterprise Ventures LLC.

Enterprise is available without charge thanks to the generous support of HSBC Egypt (tax ID: 204-901-715), the leading corporate and retail lender in Egypt; EFG Hermes (tax ID: 200-178-385), the leading financial services corporation in frontier emerging markets; SODIC (tax ID: 212-168-002), a leading Egyptian real estate developer; SomaBay (tax ID: 204-903-300), our Red Sea holiday partner; Infinity (tax ID: 474-939-359), the ultimate way to power cities, industries, and homes directly from nature right here in Egypt; CIRA (tax ID: 200-069-608), the leading providers of K-12 and higher level education in Egypt; Orascom Construction (tax ID: 229-988-806), the leading construction and engineering company building infrastructure in Egypt and abroad; Moharram & Partners (tax ID: 616-112-459), the leading public policy and government affairs partner; Palm Hills Developments (tax ID: 432-737-014), a leading developer of commercial and residential properties; Mashreq (tax ID: 204-898-862), the MENA region’s leading homegrown personal and digital bank; Industrial Development Group (IDG) (tax ID:266-965-253), the leading builder of industrial parks in Egypt; Hassan Allam Properties (tax ID:  553-096-567), one of Egypt’s most prominent and leading builders; and Saleh, Barsoum & Abdel Aziz (tax ID: 220-002-827), the leading audit, tax and accounting firm in Egypt.